EUVIMEDEUVIMED entdecken
Crossref

Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma

Taian Lin, Yixuan Hou, Xueqing Liu, Ihsan Ullah, Siyu Qiu, Zidong Lu, Jianyong Qi, Youyong Yuan iD

ACS Nano · 07.10.2025 · 19 (39) · 34659-34676

DOI: 10.1021/acsnano.5c08326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 22.09.2025. Verfasst von Taian Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, P. R. China. Hauptthemen laut MEDLINE: Sorafenib, Liver Neoplasms, Carcinoma, Hepatocellular, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangdong Administration of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibLiver NeoplasmsCarcinoma, HepatocellularDrug Resistance, NeoplasmEpigenesis, GeneticAntineoplastic AgentsHumansProteolysisAnimalsMiceCell Line, TumorHalogenationTranscription FactorsNanoparticlesCell Cycle ProteinsMice, NudeCell ProliferationProteolysis Targeting ChimeraBromodomain Containing Proteins

Stichwörter der Autor:innen

epigenetic remodelinghepatocellular carcinomamultipathway drug resistanceproteolysis targeting chimerastumor immunosuppressive microenvironment

Substanzen

SorafenibAntineoplastic AgentsBRD4 protein, humanTranscription FactorsCell Cycle ProteinsProteolysis Targeting ChimeraBromodomain Containing Proteins

Autor:innen und Institutionen

  • School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, P. R. China.
  • Intensive Care Research Team of Traditional Chinese Medicine, Guangdong Province Academy of Chinese Medicine, Guangzhou 510006, P. R. China.
  • School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.
  • National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, P. R. China.
  • Guangdong Provincial Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou 510006, P. R. China.

ORCID-Profile: Youyong Yuan

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Guangdong Administration of Chinese Medicine
  • Science and Technology Program of Guangzhou
  • High Level Construction Foundation of Guangzhou University of Chinese Medicine
  • Guangzhou Science and Technology Planning Project
  • State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation

Zitieren

APA

Lin, T., Hou, Y., Liu, X., Ullah, I., Qiu, S., Lu, Z., Qi, J., & Yuan, Y. (2025). Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma. ACS Nano, 19(39), 34659-34676. https://doi.org/10.1021/acsnano.5c08326

Vancouver

Lin T, Hou Y, Liu X, Ullah I, Qiu S, Lu Z, et al. Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma. ACS Nano. 2025;19(39):34659-34676. doi:10.1021/acsnano.5c08326

BibTeX
@article{Lin2025,
  author = {Lin, Taian and Hou, Yixuan and Liu, Xueqing and Ullah, Ihsan and Qiu, Siyu and Lu, Zidong and Qi, Jianyong and Yuan, Youyong},
  title = {Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {39},
  pages = {34659--34676},
  doi = {10.1021/acsnano.5c08326}
}
Kostenlos starten →